Greenleaf Trust’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,141
| Closed | -$219K | – | 790 |
|
|
2023
Q3 | $219K | Buy |
14,141
+2,168
| +18% | +$33.5K | ﹤0.01% | 685 |
|
|
2023
Q2 | $188K | Buy |
11,973
+339
| +3% | +$5.33K | ﹤0.01% | 731 |
|
|
2023
Q1 | $192K | Buy |
+11,634
| New | +$192K | ﹤0.01% | 740 |
|
|
2022
Q4 | – | Sell |
-22,884
| Closed | -$297K | – | 769 |
|
|
2022
Q3 | $297K | Sell |
22,884
-6,034
| -21% | -$78.3K | ﹤0.01% | 538 |
|
|
2022
Q2 | $406K | Sell |
28,918
-16,168
| -36% | -$227K | 0.01% | 465 |
|
|
2022
Q1 | $646K | Buy |
45,086
+14,484
| +47% | +$208K | 0.01% | 345 |
|
|
2021
Q4 | $417K | Buy |
30,602
+7,674
| +33% | +$105K | ﹤0.01% | 483 |
|
|
2021
Q3 | $376K | Buy |
22,928
+5,796
| +34% | +$95.1K | ﹤0.01% | 500 |
|
|
2021
Q2 | $288K | Sell |
17,132
-7,564
| -31% | -$127K | ﹤0.01% | 590 |
|
|
2021
Q1 | $451K | Buy |
+24,696
| New | +$451K | 0.01% | 409 |
|
|
2020
Q4 | – | Sell |
-19,502
| Closed | -$348K | – | 637 |
|
|
2020
Q3 | $348K | Buy |
19,502
+5,324
| +38% | +$95K | 0.01% | 374 |
|
|
2020
Q2 | $254K | Buy |
+14,178
| New | +$254K | ﹤0.01% | 441 |
|
|
2020
Q1 | – | Sell |
-19,386
| Closed | -$382K | – | 589 |
|
|
2019
Q4 | $382K | Sell |
19,386
-3,302
| -15% | -$65.1K | 0.01% | 353 |
|
|
2019
Q3 | $390K | Buy |
+22,688
| New | +$390K | 0.01% | 340 |
|
|
2019
Q2 | – | Sell |
-16,254
| Closed | -$331K | – | 562 |
|
|
2019
Q1 | $331K | Buy |
+16,254
| New | +$331K | 0.01% | 364 |
|